Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report

被引：48

作者：

Rovasalo, Aki

Tohmo, Harri

Aantaa, Riku

Kettunen, Eija

Palojoki, Rlitta

机构：

[1] Hyvinkaa Hosp, Dept Anaesthesia & Intens Care, Hyvinkaa, Finland

[2] Turku Univ Hosp, Dept Anesthesiol & Intens Care, FIN-20520 Turku, Finland

[3] Hyvinkaa Hosp, Dept Internal Med, Hyvinkaa, Finland

来源：

GENERAL HOSPITAL PSYCHIATRY | 2006年 / 28卷 / 04期

关键词：

dexmedetomidine; alcohol withdrawal; delirium; aggressive behavior; case report;

D O I：

10.1016/j.genhosppsych.2006.03.002

中图分类号：

R749 [精神病学];

学科分类号：

100205 [精神病与精神卫生学];

摘要：

In this case report, even a moderate dose of dexmedetomidine, a very selective alpha(2)-adrenergic agent, resulted in a rapid response to alcohol withdrawal delirium after the standard treatment. Psychiatrists should be aware of this relatively new drug that provides advantages over clonidine, heavy sedation and secondary restraints. Dexmedetomidine should be further evaluated in the treatment of specific forms of aggressive behavior and complicated withdrawal states. (c) 2006 Elsevier Inc. All rights reserved.

引用

页码：362 / 363

页数：2

共 6 条

[1]

Baddigam Krishna, 2005, J Intensive Care Med, V20, P118, DOI 10.1177/0885066604273481

[2]

Dexmedetomidine produces its neuroprotective effect via the α2A-adrenoceptor subtype [J].